| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Completed Research
Forum: Help Conquer Cancer
Thread: Interesting News Articles About Cancer |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 954
|
|
| Author |
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges: 
|
http://www.medicalnewstoday.com/articles/207483.php
"Article Date: 12 Nov 2010 Think Treatments For Cancer, Diabetes Don't Grow On Trees? Think Again Supported by thousands of years of use, a new wave of polymolecular botanical drugs (PBDs), backed by strong biomedical research and clinical trials, are growing in acceptance as a viable new drug category for the treatment and prevention of a wide spectrum of diseases from cancer to obesity..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/207954.php
"Article Date: 16 Nov 2010 Regular Exercise Reduces Large Number Of Health Risks Including Dementia And Some Cancers Regular exercise can reduce around two dozen physical and mental health conditions and slow down how quickly the body ages, according to a research review summarising the key findings of 40 papers published between 2006 and 2010. The paper provides an invaluable source for both news and feature editors as it is divided into a number of key sections, ranging from: "Why should I exercise" to "I'm too busy, I don't have time". Health conditions covered by the review include: cancer, heart disease, dementia, stroke, type 2 diabetes, depression, obesity and high blood pressure. People who take regular exercise could reduce their risk of developing around two dozen physical and mental health conditions - including some cancers and dementia - and slow down how quickly their body deteriorates as they age..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/207598.php
"Article Date: 17 Nov 2010 New Mechanism Leading To Anticancer Drug Resistance Identified Scientists at the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), recently identified a new biomarker to predict sensitivity to rapamycin, an immunosuppressive agent that has shown promise as a cancer therapeutic and approved for clinical application; but patients' response to this class of drugs is often unpredictable. The knowledge gained may help develop better treatment strategy for colorectal cancer. The study found that a gene, PPP2R2B, is lost in colorectal cancer and this loss results in the activation of the PDK1-Myc signalling, an important cancer pathway leading to rapamycin resistance. In addition, it was shown that the combination of rapamycin and PDKI inhibitor overcomes rapamycin resistance, which might prove useful for the treatment of colorectal cancer..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208257.php
"Article Date: 18 Nov 2010 New Drug Targets Vitamin D Receptors In Hormone Resistant Prostate Cancers: Promising Results From First Clinical Trial A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208261.php
"Article Date: 18 Nov 2010 Tiny Trojan Horses Attack Brain Cancer Cells Scientists in Germany have developed a way of smuggling an anti-cancer drug past the protective blood-brain barrier and into brain tumours and metastases using a nanocarrier - a tiny capsule specially designed to pass through cell membranes and deliver its anti-cancer drug to the cancer cell..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208266.php
"Article Date: 18 Nov 2010 PARP Inhibitor, MK-4827, Shows Anti-tumour Activity In First Trial In Humans A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans. Some patients with a range of solid tumours, many of whom had been treated unsuccessfully for their cancer with other therapies, have seen their tumours shrink or stabilise for periods of between 46 days to more than a year. The research will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208516.php
"Article Date: 18 Nov 2010 Prostate Cancer Vaccine, Provenge, Gets Green Light From Medicare Advisory Committee A $39,000 prostate cancer vaccine, Provenge (sipuleucel-T), for patients with advanced disease that extends survival by an average of four months has been recommended by the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC).." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208566.php
"Article Date: 19 Nov 2010 Compound That Blocks Sugar Pathway Slows Cancer Cell Growth Scientists at Johns Hopkins have identified a compound that could be used to starve cancers of their sugar-based building blocks. The compound, called a glutaminase inhibitor, has been tested on laboratory-cultured, sugar-hungry brain cancer cells and, the scientists say, may have the potential to be used for many types of primary brain tumors..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208785.php
"Article Date: 20 Nov 2010 Regarding The Results Of A Five-year Follow-up Study In The Adjuvant Chemotherapy Trial Of TS-1 For Gastric Cancer (ACTS-GC) Taiho Pharmaceutical Co., Ltd., announced that the results of a five-year follow-up study in the Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) was announced at the meeting of the European Society for Medical Oncology held in Milan, Italy, on October 11, 2010..." |
||
|
|
Michael2901
Veteran Cruncher Joined: Feb 6, 2009 Post Count: 586 Status: Offline Project Badges:
|
http://www.medicalnewstoday.com/articles/208781.php
"Article Date: 20 Nov 2010 Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects. Data shows that AEZS-129 and AEZS-132 block important signalling pathways (PI3K/Akt and Ras/Raf/Mek/Erk) which contribute to the proliferation and survival of cancer cells. Targeting these multiple signalling pathways could result in improved treatment efficacy for such cancers as lung, colon, prostate, breast, endometrial cancer and melanoma..." |
||
|
|
|